Seventure

MaaT Pharma announces the successful completion of its Global Offering of €9.1 million
14 November 2025

MaaT Pharma announces the successful completion of its Global Offering of €9.1 million

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...

Read more
Sunrise Group: $29 Million Raised For Expanding Dreem Health
1 October 2025

Sunrise Group: $29 Million Raised For Expanding Dreem Health

Sunrise Group, known as a leader in sleep health technology, has announced a funding round of $29 million dedicated to expanding Dreem Health, its innovative digital sleep...

Read more
With a €860,000 investment, Seventure Partners joins Kapsera’s funding round, raising its Series A to €5 million.
22 September 2025

With a €860,000 investment, Seventure Partners joins Kapsera’s funding round, raising its Series A to €5 million.

Kapsera, a pioneer in sustainable microencapsulation for the agri-food industry, announces the entry of Seventure Partners into its capital as part of its Series A financing...

Read more
MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe
2 July 2025

MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...

Read more
The top 50 venture investors in France : Seventure ranked as #7
13 June 2025

The top 50 venture investors in France : Seventure ranked as #7

We mined CB Insights data on top France-based firms to rank them based on their portfolio strength and ability to predict future winners.

Read more
MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial Evaluating MaaT013 in Acute Graft-versus-Host Disease
18 March 2025

MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial Evaluating MaaT013 in Acute Graft-versus-Host Disease

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...

Read more
SeaWeed Concept raises 2 million euros to expand production of seaweed for human consumption
21 February 2025

SeaWeed Concept raises 2 million euros to expand production of seaweed for human consumption

SeaWeed Concept, start-up specializing in the use of lacto-fermented seaweed for human consumption, has just raised 2 million euros from the Paris-based Blue Forward Fund. This...

Read more
Ekstere raises €2,4 million to make cycling truly sustainable !
12 February 2025

Ekstere raises €2,4 million to make cycling truly sustainable !

Entry of Ekstere into the Sport and Performance Capital funds of Seventure Partners.
Structuring the second-hand bike market through listing.
Make sustainable...

Read the press release
Anybuddy raises €2M with Seventure Partners’ Sport & Performance Capital fund and becomes the benchmark in racquet sports by accelerating its focus on padel.
6 February 2025

Anybuddy raises €2M with Seventure Partners’ Sport & Performance Capital fund and becomes the benchmark in racquet sports by accelerating its focus on padel.

Anybuddy, France's leading racquet sports booking platform, has announced a €2 million round of financing to support its expansion and enhance its service offering.
By...

Read the press release
Starfish signs an agreement with BioAster to expand its understanding of anaerobic soil bacteria
10 December 2024

Starfish signs an agreement with BioAster to expand its understanding of anaerobic soil bacteria

Starfish Bioscience, a specialist in microbiome-based solutions for soil regeneration, has just signed a partnership agreement with BioAster. This collaboration will expand...

Read more